Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial

INTRODUCTION: As the role of (neuro)inflammation in depression pathophysiology is emerging, augmentation of antidepressant treatments with anti-inflammatory drugs have shown beneficial results, but not consistently across all studies. Inconsistencies may be due to depression biological and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwiep, J.C., Bet, P.M., Rhebergen, D., Nurmohamed, M.T., Vinkers, C.H., Penninx, B.W.J.H., Milaneschi, Y., Lamers, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841030/
https://www.ncbi.nlm.nih.gov/pubmed/36655056
http://dx.doi.org/10.1016/j.bbih.2022.100585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841030/
https://www.ncbi.nlm.nih.gov/pubmed/36655056
http://dx.doi.org/10.1016/j.bbih.2022.100585

Ejemplares similares